These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24278292)

  • 1. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
    Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
    PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
    Goad DW; Nesmelova AY; Yohe LR; Grdzelishvili VZ
    J Virol; 2023 Sep; 97(9):e0100523. PubMed ID: 37671865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo.
    Li J; Qian W; Qin T; Xiao Y; Cheng L; Cao J; Chen X; Ma Q; Wu Z
    Comput Struct Biotechnol J; 2019; 17():498-506. PubMed ID: 31011408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α
    Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
    Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
    J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
    Lakshmanan I; Marimuthu S; Chaudhary S; Seshacharyulu P; Rachagani S; Muniyan S; Chirravuri-Venkata R; Atri P; Rauth S; Nimmakayala RK; Siddiqui JA; Gautam SK; Shah A; Natarajan G; Parte S; Bhyravbhatla N; Mallya K; Haridas D; Talmon GA; Smith LM; Kumar S; Ganti AK; Jain M; Ponnusamy MP; Batra SK
    Oncogene; 2022 Nov; 41(48):5147-5159. PubMed ID: 36271032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zeb1 in Stromal Myofibroblasts Promotes
    Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
    Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer.
    Goetze RG; Buchholz SM; Ou N; Zhang Q; Patil S; Schirmer M; Singh SK; Ellenrieder V; Hessmann E; Lu QB; Neesse A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31181844
    [No Abstract]   [Full Text] [Related]  

  • 10. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry.
    An X; Ouyang X; Zhang H; Li T; Huang YY; Li Z; Zhou D; Li QX
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.
    Pfisterer N; Ammer-Herrmenau C; Antweiler K; Küffer S; Ellenrieder V; Neesse A
    Pancreatology; 2023 Sep; 23(6):663-673. PubMed ID: 37541802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
    Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
    Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
    Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
    Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance.
    Ariston Gabriel AN; Jiao Q; Yvette U; Yang X; Al-Ameri SA; Du L; Wang YS; Wang C
    Pancreatology; 2020 Jan; 20(1):79-88. PubMed ID: 31780287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival of pancreatic ductal adenocarcinoma is doubled by
    Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY
    Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098
    [No Abstract]   [Full Text] [Related]  

  • 18. GEMMs as preclinical models for testing pancreatic cancer therapies.
    Gopinathan A; Morton JP; Jodrell DI; Sansom OJ
    Dis Model Mech; 2015 Oct; 8(10):1185-200. PubMed ID: 26438692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.
    Majumder K; Arora N; Modi S; Chugh R; Nomura A; Giri B; Dawra R; Ramakrishnan S; Banerjee S; Saluja A; Dudeja V
    J Gastrointest Surg; 2016 Jan; 20(1):53-65; discussion 65. PubMed ID: 26582596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
    Lee JW; Komar CA; Bengsch F; Graham K; Beatty GL
    Curr Protoc Pharmacol; 2016 Jun; 73():14.39.1-14.39.20. PubMed ID: 27248578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.